...
首页> 外文期刊>Journal of the International Aids Society >HIV testing and the care continuum among transgender women: population estimates from Rio de Janeiro, Brazil
【24h】

HIV testing and the care continuum among transgender women: population estimates from Rio de Janeiro, Brazil

机译:艾滋病检测和变性妇女的护理连续性:巴西里约热内卢的人口估计

获取原文
           

摘要

Introduction: Evidence suggests that, of all affected populations, transgender women (transwomen) may have the heaviest HIV burden worldwide. Little is known about HIV linkage and care outcomes for transwomen. We aimed to estimate population‐level indicators of the HIV cascade of care continuum, and to evaluate factors associated with viral suppression among transwomen in Rio de Janeiro, Brazil. Methods: We conducted a respondent‐driven sampling (RDS) study of transwomen from August 2015 to January 2016 in Rio de Janeiro, Brazil and collected data on linkage and access to care, antiretroviral treatment and performed HIV viral load testing. We derived population‐based estimates of cascade indicators using sampling weights and conducted RDS‐weighted logistic regression analyses to evaluate correlates of viral suppression (viral load ≤50 copies/mL). Results: Of the 345 transwomen included in the study, 89.2% (95% CI 55–100%) had been previously tested for HIV, 77.5% (95% CI 48.7–100%) had been previously diagnosed with HIV, 67.2% (95% CI 39.2–95.2) reported linkage to care, 62.2% (95% CI 35.4–88.9) were currently on ART and 35.4% (95% CI 9.5–61.4%) had an undetectable viral load. The final adjusted RDS‐weighted logistic regression model for viral suppression indicated that those who self‐identified as black (adjusted odds ratio [aOR] 0.06, 95% CI 0.01–0.53, p Conclusions: Our cascade indicators for transwomen showed modest ART use and low viral suppression rates. Multi‐level efforts including gender affirming care provision are urgently needed to decrease disparities in HIV clinical outcomes among transwomen and reduce secondary HIV transmission to their partners.
机译:简介:有证据表明,在所有受影响人群中,跨性别女性(跨性别女性)可能是全世界艾滋病毒负担最重的人群。关于艾滋病毒与妇女的联系和护理成果知之甚少。我们的目的是估计艾滋病毒护理连续性的艾滋病毒级联指标,并评估与巴西里约热内卢的跨性别女性中病毒抑制相关的因素。方法:我们于2015年8月至2016年1月在巴西里约热内卢开展了一项针对女性跨性别者的抽样调查(RDS),收集了有关联系和获得护理,抗逆转录病毒治疗的数据,并进行了HIV病毒载量测试。我们使用抽样权重得出了基于人群的级联指标估计,并进行了RDS加权逻辑回归分析以评估病毒抑制的相关性(病毒载量≤50拷贝/ mL)。结果:在研究中包括的345名女性中,有89.2%(95%CI 55-100%)曾接受过HIV检测,有77.5%(95%CI 48.7-100%)先前已被诊断出HIV,有67.2%(95%CI 48.7-100%)。 95%的CI 39.2–95.2)报告了与护理的联系,目前有62.2%(95%的CI 35.4–88.9)接受抗病毒治疗,而35.4%(95%的CI 9.5–61.4%)具有无法检测到的病毒载量。最终针对病毒抑制的调整后RDS加权逻辑回归模型表明,那些自我识别为黑人的人(调整后的优势比[aOR] 0.06,95%CI 0.01-0.53,p)结论:我们的跨性别指标显示适度使用ART和低病毒抑制率:迫切需要多方努力,包括提供性别确认护理,以减少跨性别者艾滋病毒临床结果之间的差异,并减少艾滋病毒向其伴侣的继发性传播。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号